Real-time US stock option implied volatility surface analysis and expected move calculations for trading strategies and risk management. We use options pricing models to derive market expectations for stock movement over different time periods and expiration dates. We provide IV analysis, expected move calculations, and volatility surface modeling for comprehensive coverage. Understand option market expectations with our comprehensive IV analysis and move calculation tools for options trading.
Neuphoria Therapeutics Inc. (NEUP) is trading at $4.78 as of 2026-04-04, posting a 1.27% gain in today’s session. This analysis covers key technical levels, recent market context, and potential near-term scenarios for the clinical-stage biotech stock, with no recent earnings data available for the company as of this writing. Key observations include well-defined near-term support and resistance levels, mixed trading volume in recent sessions, and sensitivity to broader small-cap biotech sector t
How does macroeconomics affect Neuphoria Therapeutics (NEUP) Stock | Price at $4.78, Up 1.27% - Volatility Breakout
NEUP - Stock Analysis
3501 Comments
1289 Likes
1
Kamerra
Active Contributor
2 hours ago
Free US stock ESG scoring and sustainability analysis for responsible investing considerations. We evaluate environmental, social, and governance factors that increasingly impact long-term company performance.
👍 237
Reply
2
Shinese
Experienced Member
5 hours ago
This feels like a signal.
👍 140
Reply
3
Khawlah
Returning User
1 day ago
Insightful take on the factors driving market momentum.
👍 137
Reply
4
Corwin
Experienced Member
1 day ago
This would’ve helped me make a better decision.
👍 102
Reply
5
Cassien
Legendary User
2 days ago
Short-term price swings indicate selective investor activity, highlighting sectors with the strongest performance.
👍 94
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.